BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22910912)

  • 1. Proline-mediated proteasomal degradation of the prostate-specific tumor suppressor NKX3.1.
    Rao V; Guan B; Mutton LN; Bieberich CJ
    J Biol Chem; 2012 Oct; 287(43):36331-40. PubMed ID: 22910912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitination by TOPORS regulates the prostate tumor suppressor NKX3.1.
    Guan B; Pungaliya P; Li X; Uquillas C; Mutton LN; Rubin EH; Bieberich CJ
    J Biol Chem; 2008 Feb; 283(8):4834-40. PubMed ID: 18077445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory cytokines induce phosphorylation and ubiquitination of prostate suppressor protein NKX3.1.
    Markowski MC; Bowen C; Gelmann EP
    Cancer Res; 2008 Sep; 68(17):6896-901. PubMed ID: 18757402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilization of the prostate-specific tumor suppressor NKX3.1 by the oncogenic protein kinase Pim-1 in prostate cancer cells.
    Padmanabhan A; Gosc EB; Bieberich CJ
    J Cell Biochem; 2013 May; 114(5):1050-7. PubMed ID: 23129228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nkx3.1 functions as para-transcription factor to regulate gene expression and cell proliferation in non-cell autonomous manner.
    Zhou J; Qin L; Tien JC; Gao L; Chen X; Wang F; Hsieh JT; Xu J
    J Biol Chem; 2012 May; 287(21):17248-17256. PubMed ID: 22465996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulating NKX3.1 stability and function: Post-translational modifications and structural determinants.
    Padmanabhan A; Rao V; De Marzo AM; Bieberich CJ
    Prostate; 2016 May; 76(6):523-33. PubMed ID: 26841725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Tumor Suppressor NKX3.1 Is Targeted for Degradation by DYRK1B Kinase.
    Song LN; Silva J; Koller A; Rosenthal A; Chen EI; Gelmann EP
    Mol Cancer Res; 2015 May; 13(5):913-22. PubMed ID: 25777618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional activation of ATM by the prostate cancer suppressor NKX3.1.
    Bowen C; Ju JH; Lee JH; Paull TT; Gelmann EP
    Cell Rep; 2013 Aug; 4(3):516-29. PubMed ID: 23890999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis.
    Li Y; Zhou Z; Chen C
    Cell Death Differ; 2008 Dec; 15(12):1941-51. PubMed ID: 18806757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of PTEN Accelerates NKX3.1 Degradation to Promote Prostate Cancer Progression.
    Bowen C; Ostrowski MC; Leone G; Gelmann EP
    Cancer Res; 2019 Aug; 79(16):4124-4134. PubMed ID: 31213464
    [No Abstract]   [Full Text] [Related]  

  • 11. Two Degradation Pathways of the p35 Cdk5 (Cyclin-dependent Kinase) Activation Subunit, Dependent and Independent of Ubiquitination.
    Takasugi T; Minegishi S; Asada A; Saito T; Kawahara H; Hisanaga S
    J Biol Chem; 2016 Feb; 291(9):4649-57. PubMed ID: 26631721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NKX3.1 is regulated by protein kinase CK2 in prostate tumor cells.
    Li X; Guan B; Maghami S; Bieberich CJ
    Mol Cell Biol; 2006 Apr; 26(8):3008-17. PubMed ID: 16581776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9-Mediated Point Mutation in
    Bowen C; Shibata M; Zhang H; Bergren SK; Shen MM; Gelmann EP
    Cancer Res; 2020 Nov; 80(21):4805-4814. PubMed ID: 32943441
    [No Abstract]   [Full Text] [Related]  

  • 14. Hedgehog signaling promotes the degradation of tumor suppressor Sufu through the ubiquitin-proteasome pathway.
    Yue S; Chen Y; Cheng SY
    Oncogene; 2009 Jan; 28(4):492-9. PubMed ID: 18997815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Nkx3.1 enhances 17beta-estradiol anti-tumor action in PC3 human prostate cancer cells.
    Wang P; Liu B; Luo JD; Zhang ZG; Ma Q; Chen ZD
    Asian J Androl; 2007 May; 9(3):353-60. PubMed ID: 17486276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation of the homeobox gene NKX3.1 by all-trans retinoic acid in prostate cancer cells.
    Thomas MA; Hodgson MC; Loermans SD; Hooper J; Endersby R; Bentel JM
    J Cell Biochem; 2006 Dec; 99(5):1409-19. PubMed ID: 16817226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
    Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
    Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressor.
    Scaglioni PP; Yung TM; Choi S; Baldini C; Konstantinidou G; Pandolfi PP
    Mol Cell Biochem; 2008 Sep; 316(1-2):149-54. PubMed ID: 18566754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haploinsufficient prostate tumor suppression by Nkx3.1: a role for chromatin accessibility in dosage-sensitive gene regulation.
    Mogal AP; van der Meer R; Crooke PS; Abdulkadir SA
    J Biol Chem; 2007 Aug; 282(35):25790-800. PubMed ID: 17602165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of the homeotic tumor suppressor Cdx2 mediates its ubiquitin-dependent proteasome degradation.
    Gross I; Lhermitte B; Domon-Dell C; Duluc I; Martin E; Gaiddon C; Kedinger M; Freund JN
    Oncogene; 2005 Dec; 24(54):7955-63. PubMed ID: 16027724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.